Mar 06, 2025 / 09:30PM GMT
Operator
Thank you for standing by and welcome to the Profound Medical fourth-quarter and full-year 2024 financial results conference call. (Operator Instructions) As a reminder, today's program is being recorded.
And now I'd like to introduce your host for today's program, Stephen Kilmer, Investor Relations. Please go ahead, sir.
Stephen Kilmer - Profound Medical Corp - Investor Relations
Thank you. Good afternoon, everyone. Let me start by pointing out that this conference call will include forward-looking statements within the meaning of applicable securities laws in the United States and Canada.
All forward-looking statements are based on profound current beliefs, assumptions, and expectations and relate to, among other things, any expressed or implied statements or guidance regarding current or financial performance and position, the expectations regarding the efficacy of profound technology in the treatment of prostate cancer, BPH, uterine uterine fibroids, palliative pain treatment, and osteoid osteoma, and its future revenues financial results.
Q4 2024 Profound Medical Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
